49,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
25 °P sammeln
  • Broschiertes Buch

This book explores the emerging therapeutic potential of purinergic signaling modulation across different stages of cerebrovascular injury. It presents a comprehensive overview of how P2X4 receptor activation or inhibition affects microglial polarization, neuroinflammation, neuronal survival, and post-stroke behavioral outcomes. Integrating molecular neuroscience, pharmacology, and translational medicine, the text delineates the dual temporal roles of P2X4 receptors-early neuroprotection in acute ischemia and regulation of neuroplasticity to mitigate chronic post-stroke depression. The book…mehr

Produktbeschreibung
This book explores the emerging therapeutic potential of purinergic signaling modulation across different stages of cerebrovascular injury. It presents a comprehensive overview of how P2X4 receptor activation or inhibition affects microglial polarization, neuroinflammation, neuronal survival, and post-stroke behavioral outcomes. Integrating molecular neuroscience, pharmacology, and translational medicine, the text delineates the dual temporal roles of P2X4 receptors-early neuroprotection in acute ischemia and regulation of neuroplasticity to mitigate chronic post-stroke depression. The book highlights recent experimental models, receptor-selective ligands, and clinical perspectives for designing time-sensitive interventions that bridge acute neuroprotection with long-term mental health recovery in stroke patients.
Autorenporträt
Dr.R.M.Heris, M.D, Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.Dr.H.Aghazadeh, Pharm.D, M.Pharm.Eng., MBA Pharma, B.Sc. Microbiology.Dr.A.Tahavvori, M.D. Internal Medicine Specialist, Laboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, US.